ExonHit Therapeutics Inc. Extends Strategic Collaboration with Allergan Inc.
Published: Nov 02, 2011
PARIS--(BUSINESS WIRE)--Regulatory News: ExonHit S.A. (Alternext: ALEHT) today announced the extension of its existing drug discovery collaboration with Allergan Sales, LLC (NYSE: AGN). The collaboration was initiated in December 2002, and extended several times. It now is further extended until December 2013. The collaboration will continue to focus on the identification, development and commercialization of drugs for the treatment of neurodegenerative diseases, pain and ophthalmology.